Vaccine News and Research

Latest Vaccine News and Research

Abortion of female fetuses in northern India results in gender imbalance

Modern ultrasound technology and economic pressure leads to female fetuses in the Ballabgarh area of northern India being aborted more often than male fetuses. Additionally, girls up to the age of five die more frequently than boys, which results in a gender imbalance in the area, according to Anand Krishnan, MD and doctoral candidate at Ume- University, who defends his thesis on 11 October.

9 Oct 2013

Researchers recently launched Collaborative Hepatitis Network in Africa

Although it does not receive as much attention as AIDS, hepatitis has long been one of Africa's most serious health problems.

9 Oct 2013

Salk scientist receives Career Development Award for new research from JDRF

The Juvenile Diabetes Research Foundation has given Salk scientist Mark Huising a five-year, $750,000 Career Development Award for his proposed study on how a novel network of receptors in human islets receives and integrates molecular signals. In pre-clinical models, activation of these receptors has proven to actually prevent diabetes.

9 Oct 2013

Healthcare providers report unaccompanied teens may not receive required vaccines

Healthcare providers report that older teens often go to the doctor without a parent or guardian, a new survey in the Journal of Adolescent Health reveals—and those teens may not get necessary vaccinations because there's no parent or guardian present to give consent.

9 Oct 2013

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

9 Oct 2013

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

A new analysis of two HIV vaccine trials that involved pediatric patients shows that the investigational vaccines stimulated a critical immune response in infants born to HIV-infected mothers, researchers at Duke Medicine report.

9 Oct 2013

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease.

9 Oct 2013

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Malaria researcher Professor Alan Cowman from the Walter and Eliza Hall Institute has been awarded the 2013 Victoria Prize for Science and Innovation in recognition of his outstanding contributions in the quest to eradicate malaria.

8 Oct 2013

Researchers use ARRAYit Microarray Platform to discover important biomarkers

ARRAYit Corporation reports today that researchers at the National Institutes of Health (NIH), National Cancer Institute (NCI) and Northeastern University have used the ARRAYit Microarray Platform to discover biomarkers important in the treatment of prostate cancer.

8 Oct 2013

Vaccination campaign led HBV to more than double rate of "breakout" mutations

A universal infant vaccination campaign in China has led the Hepatitis B virus (HBV) to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies.

8 Oct 2013

Research: Vaccine against norovirus reduces symptoms of illness by 52%

An investigational vaccine appears generally well tolerated and effective against the most common strain of norovirus, reducing the main symptoms of the gastrointestinal (GI) infection, vomiting and/or diarrhea, by 52 percent, suggests research being presented at IDWeek 2013.

5 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

MSU receives $10M grant to further research on diseases that affect animal, human health

Mississippi State University has been awarded a $10 million grant for five years of support from the National Institutes of Health to further research focusing on diseases that affect animal and human health.

4 Oct 2013

J&J's Janssen Companies Launch A Trio Of Collaborations

...

3 Oct 2013

CureVac collaborates with Janssen on development of influenza vaccine based on mRNA

CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.

3 Oct 2013

McMaster vaccine offers new hopes for global fight against TB

A tuberculosis vaccine developed at McMaster University offers new hopes for the global fight against tuberculosis.

3 Oct 2013

Research recommends that pediatricians respect parents' rights in making case for immunization

Controversy about the risks of measles, mumps, and rubella vaccines has been rumbling in the United States for years -- and now it's Israel's turn. After finding traces of the polio virus in sewage, Israel's Ministry of Health launched a national vaccination campaign that reached more than half a million children. Surprisingly, dissenting voices flooded social media and the mainstream news, calling for a halt to the campaign.

2 Oct 2013

Researchers develop new approach to combat tubercle bacillus

A new approach to combating the tubercle bacillus, the microorganism that kills some 1.5 million people in the world each year, has been developed by a French-British team including scientists from CNRS, Inserm, the Institut Curie and Université Toulouse III - Paul Sabatier.

2 Oct 2013

New research shows no increased danger for egg allergic children who take flu shots

All children should have flu shots, even if they have an egg allergy, and it's now safe to get them without special precautions. This finding is from the latest update on the safety of the flu vaccine for allergic patients, published in the October issue of the Annals of Allergy, Asthma and Immunology, the official journal of the American College of Allergy, Asthma and Immunology.

2 Oct 2013

Study assess use of prescription painkillers for chronic pain among patients pre- and post-obesity surgery

Chronic use of prescription painkillers, also known as opioids, among obese patients prior to bariatric surgery continues after surgery, according to a new Kaiser Permanente study published today in the Journal of the American Medical Association.

2 Oct 2013

Vaccine News and Research

Latest Vaccine News and Research

Abortion of female fetuses in northern India results in gender imbalance

Researchers recently launched Collaborative Hepatitis Network in Africa

Salk scientist receives Career Development Award for new research from JDRF

Healthcare providers report unaccompanied teens may not receive required vaccines

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

New HIV vaccines stimulate critical immune response in infants born to HIV-infected mothers

FMCNA encourages dialysis patients to get vaccinated against flu

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Researchers use ARRAYit Microarray Platform to discover important biomarkers

Vaccination campaign led HBV to more than double rate of "breakout" mutations

Research: Vaccine against norovirus reduces symptoms of illness by 52%

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

MSU receives $10M grant to further research on diseases that affect animal, human health

J&J's Janssen Companies Launch A Trio Of Collaborations

CureVac collaborates with Janssen on development of influenza vaccine based on mRNA

McMaster vaccine offers new hopes for global fight against TB

Research recommends that pediatricians respect parents' rights in making case for immunization

Researchers develop new approach to combat tubercle bacillus

New research shows no increased danger for egg allergic children who take flu shots

Study assess use of prescription painkillers for chronic pain among patients pre- and post-obesity surgery

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in